Form 8-K - Current report:
SEC Accession No. 0001558370-24-013387
Filing Date
2024-10-18
Accepted
2024-10-18 06:35:59
Documents
16
Period of Report
2024-10-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20241018x8k.htm   iXBRL 8-K 44152
2 EX-99.1 tmb-20241018xex99d1.htm EX-99.1 19244
3 GRAPHIC tmb-20241018xex99d1001.jpg GRAPHIC 5563
  Complete submission text file 0001558370-24-013387.txt   200951

Data Files

Seq Description Document Type Size
4 EX-101.SCH tmb-20241018.xsd EX-101.SCH 3936
5 EX-101.DEF tmb-20241018_def.xml EX-101.DEF 2808
6 EX-101.LAB tmb-20241018_lab.xml EX-101.LAB 16549
7 EX-101.PRE tmb-20241018_pre.xml EX-101.PRE 9657
18 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20241018x8k_htm.xml XML 4725
Mailing Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059
Business Address 500 WARREN CORPORATE CENTER DRIVE WARREN NJ 07059 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

EIN.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35969 | Film No.: 241378869
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)